Claudin-18.2 targeting by zolbetuximab: results of SPOTLIGHT in perspective

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Citations (Scopus)

Access to Document

@article{a0179e1e527b4414bd7f50c5daf60ba4,

title = "Claudin-18.2 targeting by zolbetuximab: results of SPOTLIGHT in perspective",

author = "{van Laarhoven}, {Hanneke W. M.} and Sarah Derks",

year = "2023",

month = may,

day = "20",

doi = "https://doi.org/10.1016/S0140-6736(23)00732-8",

language = "English",

volume = "401",

pages = "1630--1631",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10389",

}

TY - JOUR

T1 - Claudin-18.2 targeting by zolbetuximab

T2 - results of SPOTLIGHT in perspective

AU - van Laarhoven, Hanneke W. M.

AU - Derks, Sarah

PY - 2023/5/20

Y1 - 2023/5/20

UR - http://www.scopus.com/inward/record.url?scp=85153845020&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S0140-6736(23)00732-8

DO - https://doi.org/10.1016/S0140-6736(23)00732-8

M3 - Comment/Letter to the editor

C2 - 37068506

SN - 0140-6736

VL - 401

SP - 1630

EP - 1631

JO - The Lancet

JF - The Lancet

IS - 10389

ER -